Arterial hypertension and cognitive disorders. Mexidol's effectiveness

Time codes:
  • 02:30

    Portrait of a patient with arterial hypertension

  • 05:24

    The brain is an organ of the target of arterial hypertension. 

  • 06:00

    Approach to early diagnosis of patients 

  • 08:00

    Montreal scale for evaluating cognitive functions (Mosa –Test)

  • 09:08

    Digital symbol replacement test 

  • 09:40

    Trail Making Test (TMT)

  • 11:10

    Target levels of blood pressure 

  • 12:15

    Antihypertensive drugs and related risk factors

  • 14:10

    Features of neuroprotectors for patients with arterial hypertension

  • 19:14

    Mexidol® is an effective neuroprotector with evidence

  • 19:50

    Long -term and consistent therapy with Mexidol® in a memo study  

Ekusheva Evgenia Viktorovna - MD, professor, head. Department of Nervous Diseases and Neurorebition of the Academy of Postgraduate Education of the Federal State Budgetary Educational Institution of the FGBC FMBA of Russia

Kochetkov Alexey Ivanovich - Ph.D., associate professor of the Department of Therapy and Polymorbid Pathology named after Acad. M.S. VLUSSi FSBEI DPO RMANPO of the Ministry of Health of Russia

Announcement:

The brain is one of the main target organs of arterial hypertension. The most common cerebral symptoms of arterial hypertension should include headaches mainly in the nape area, as a rule, in the morning, dizziness of varying degrees of severity, noise in the ears and visual impairment. Mexidol® is a drug that has an evidence base and is effective for patients with arterial hypertension.

Time codes:
  • 02:30

    Portrait of a patient with arterial hypertension

  • 05:24

    The brain is an organ of the target of arterial hypertension. 

  • 06:00

    Approach to early diagnosis of patients 

  • 08:00

    Montreal scale for evaluating cognitive functions (Mosa –Test)

  • 09:08

    Digital symbol replacement test 

  • 09:40

    Trail Making Test (TMT)

  • 11:10

    Target levels of blood pressure 

  • 12:15

    Antihypertensive drugs and related risk factors

  • 14:10

    Features of neuroprotectors for patients with arterial hypertension

  • 19:14

    Mexidol® is an effective neuroprotector with evidence

  • 19:50

    Long -term and consistent therapy with Mexidol® in a memo study  

Block of articles on this topic

Resolution of the Council of Experts "The possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders"
Cognitive disorders in the practice of a primary link: Focus for patients with arterial hypertension

Authors:
O.D. Ostroumova, A.I. Kochetkov, N.A. Shatalova

Mexidol® and Mexidol® Fort 250 as part of the sequential therapy for cognitive disorders in comorbide patients with joint pathology against the background of arterial hypertension and coronary heart disease

Authors:
L.N. Eliseeva, S.V. Kartashova

FSBEI in Kuban State Medical University of the Ministry of Health of Russia, Krasnodar

The importance of identifying and diagnosing signs of brain damage to arterial hypertension

Authors:
T.M. Ostroumova, O.D. Ostroumova

International multicenteric randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250 (study of memo): Subanalysis results in patients with arterial hypertension

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com